Cancer

TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Symptomatic Thyroid Disease on December 15, 2025

WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company integrating novel delivery technology with…

57 minutes ago

Soligenix Inc. (NASDAQ: SNGX) Advancing Rare-Disease Therapies Positioned at Pivotal Crossroad

NEW YORK, Dec. 05, 2025 (GLOBE NEWSWIRE) -- via BioMedWire: — Soligenix Inc. (NASDAQ: SNGX) today announces its placement in…

1 hour ago

New Cretostimogene Grenadenorepvec Data Highlight its Potential to Become the Backbone Therapy for High-Risk Non-Muscle Invasive Bladder Cancer

Cretostimogene demonstrated HG-EFS at 3- 6- and 9-months of 95.7%, 84.6% and 80.4%, respectively, in HR BCG UR Ta/T1 Disease…

1 hour ago

GeneLife Expands GeneAI Forecast With New Cancer Risk Prediction Models

AI-Driven Risk Prediction for Breast, Prostate and Pancreatic CancersTOKYO, Dec. 05, 2025 (GLOBE NEWSWIRE) -- A.D.A.M. Innovations Co. (Japanese Name:…

1 hour ago

Medi-Weightloss Celebrates 10 Million Pounds Lost, Improving Lives and Reducing Healthcare Costs

A leader in medically supervised weight management, proudly announces a major milestone: more than 10 million pounds lost collectively by…

16 hours ago

Korea University Researchers Create Hydrogel Platform for High-Throughput Extracellular Vesicle Isolation

A meso–macroporous hydrogel enables rapid, scalable extracellular vesicle isolation from diverse biofluids without preprocessing stepsSEOUL, South Korea, Dec. 4, 2025…

22 hours ago

Caris Life Sciences to Showcase 19 Studies at the 2025 San Antonio Breast Cancer Symposium

IRVING, Texas, Dec. 4, 2025 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine…

22 hours ago

PreciseDxⓇ Presents New Data for PreciseBreastⓇ, an AI Digital Pathology Test to Predict Breast Cancer Recurrence, at the 2025 San Antonio Breast Cancer Symposium

NEW YORK, Dec. 4, 2025 /PRNewswire/ -- PreciseDx, the leading innovator behind PreciseBreast, a novel AI digital pathology test, announces the…

22 hours ago

Paradigm Health Raises $78 Million Series B to Make Clinical Trials Part of Routine Care Across the U.S. and Globally

COLUMBUS, Ohio and NEW YORK, Dec. 4, 2025 /PRNewswire/ -- Paradigm Health, the technology company rebuilding the clinical research ecosystem,…

22 hours ago

Paradigm Health Acquires Flatiron Health’s Clinical Research Business and Forms Strategic Partnership to Rebuild Clinical Research Ecosystem

Partnership creates the largest oncology research network in the United States, enabling clinical trials to reach rural and community-based practices…

22 hours ago